Joly P, Murrell DF, Aoyama Y, Caux F, et al. Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial. Br J Dermatol 2026;195:750-762.
PMID: 42723554